Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarhad Alnajjar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2025
Lamb Model of RSV InfectionSarhad Alnajjar, Jack Gallup, Mark Ackermann
Cell and Tissue Research|April 30, 2020
A model of respiratory syncytial virus (RSV) infection of infants in newborn lambsPanchan Sitthicharoenchai, Sarhad Alnajjar, Mark R Ackermann
Plos One|March 11, 2021
Streptococcus pneumoniae serotype 22F infection in respiratory syncytial virus infected neonatal lambs enhances morbiditySarhad Alnajjar, Panchan Sitthicharoenchai, Jack Gallup, et al.
The Journal of General Virology|December 11, 2024
Therapeutic efficacy of JNJ-49214698, an RSV fusion inhibitor, in RSV-infected neonatal lambsSarhad Alnajjar, Alejandro Larios-Mora, Albert Van-Geelen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2024
Inhaled "Muco-Trapping" Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) InfectionsMorgan D McSweeney, Sarhad Alnajjar, Alison M Schaefer, et al.
Journal of Medicinal Chemistry|August 6, 2024
Discovery of <i>gem</i>-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase InhibitorsSandrine Grosse, Ludwig Cooymans, Werner Embrechts, et al.
Antiviral Research|May 21, 2024
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymeraseBrecht Bonneux, Afzaal Shareef, Sergey Tcherniuk, et al.
Environment International|August 3, 2025
Mapping the evidence of the effects of environmental factors on the prevalence of antibiotic resistance in the non-built environmentIñaki Deza-Cruz, Alexandre de Menezes, Brian Gardner, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2025
Lamb Model of RSV InfectionSarhad Alnajjar, Jack Gallup, Mark Ackermann
Cell and Tissue Research|April 30, 2020
A model of respiratory syncytial virus (RSV) infection of infants in newborn lambsPanchan Sitthicharoenchai, Sarhad Alnajjar, Mark R Ackermann
Plos One|March 11, 2021
Streptococcus pneumoniae serotype 22F infection in respiratory syncytial virus infected neonatal lambs enhances morbiditySarhad Alnajjar, Panchan Sitthicharoenchai, Jack Gallup, et al.
The Journal of General Virology|December 11, 2024
Therapeutic efficacy of JNJ-49214698, an RSV fusion inhibitor, in RSV-infected neonatal lambsSarhad Alnajjar, Alejandro Larios-Mora, Albert Van-Geelen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2024
Inhaled "Muco-Trapping" Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) InfectionsMorgan D McSweeney, Sarhad Alnajjar, Alison M Schaefer, et al.
Journal of Medicinal Chemistry|August 6, 2024
Discovery of <i>gem</i>-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase InhibitorsSandrine Grosse, Ludwig Cooymans, Werner Embrechts, et al.
Antiviral Research|May 21, 2024
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymeraseBrecht Bonneux, Afzaal Shareef, Sergey Tcherniuk, et al.
Environment International|August 3, 2025
Mapping the evidence of the effects of environmental factors on the prevalence of antibiotic resistance in the non-built environmentIñaki Deza-Cruz, Alexandre de Menezes, Brian Gardner, et al.
Pageof 1